European Life Sciences Landscape - Genetic Technology TOE

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Genetic Technology TOE depicts trends in the current landscape and the new life sciences trends across Europe.In this TOE, silica-based drug delivery solutions, light-based technologies in life sciences, advancements in topical skin treatments, and gene discovery platforms for novel drug products and stem cells in cancer therapy innovations, are of note. The corresponding patent scenario is also depicted, along with the industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisi

Table of Contents

European Life Sciences Landscape - Genetic Technology TOETechnology ProfilesInnovative Silica-based Drug Delivery Solution Using Light-based Technology for Developing Effective Topical Skin TreatmentsGene Discovery Platform Leads to Development of Novel Drug ProductsInnovative Cancer Therapies Using Mesenchymal Stem Cells AppendixPatent ScenarioPatent ScenarioIndustry Interactions

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.